Lista de obras - Theresa A. Guise - Dominio Público Uruguay

A "Connexin" Responsible for the Fatal Attraction of Cancer to Bone

A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases

artículo científico publicado en 2003

Actions of bisphosphonates in animal models of breast cancer

artículo científico publicado en 2001

Ad5/48 hexon oncolytic virus expressing sTGFβRIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases

artículo científico publicado en 2014

Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis

artículo científico publicado en 2006

Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference

artículo científico publicado en 2006

Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference

artículo científico publicado en 2008

Agents targeting prostate cancer bone metastasis

scientific article published on December 2009

Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker

scientific article published on 21 June 2018

Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation

artículo científico publicado en 2010

Antitumor effects of bisphosphonates: promising preclinical evidence

artículo científico publicado en 2008

Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo

artículo científico publicado en 2016

Assessing new bone formation in neonatal calvarial organ cultures

artículo científico publicado en 2008

BMP7: a new bone metastases prevention?

artículo científico publicado en 2007

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

artículo científico publicado en 2006

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

article

Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer

artículo científico publicado en 2020

Bone loss and fracture risk associated with cancer therapy

artículo científico publicado en 2006

Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases

artículo científico publicado en 2017

Breaking Down Barriers to Chemoresistance: Role of Chemotherapy-Induced Osteoblastic Jagged1.

artículo científico publicado en 2017

Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases

artículo científico publicado en 2009

Breaking new ground to build bone

artículo científico publicado en 2007

Breast cancer bone metastases: it's all about the neighborhood

artículo científico publicado en 2013

Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy

artículo científico publicado en 2005

Cancer to bone: a fatal attraction ⬇️

artículo científico publicado el 19 de mayo de 2011

Cancer treatment-related bone disease

artículo científico publicado en 2009

Cancer-associated bone disease

artículo científico publicado en 2007

Cancer-associated muscle weakness: What's bone got to do with it?

artículo científico

Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror

artículo científico publicado en 2013

Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity

scientific article published on 01 June 2019

Corrigendum: Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin

artículo científico publicado en 2015

Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis

artículo científico publicado en 2012

Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad

artículo científico publicado en 2012

Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy

artículo científico publicado en 2006

Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation

artículo científico publicado en 2006

Differential Bone Loss in Mouse Models of Colon Cancer Cachexia

artículo científico publicado en 2016

Differential stem- and progenitor-cell trafficking by prostaglandin E2.

artículo científico publicado en 2013

Do markers of bone turnover predict clinical outcome in patients with bone metastases?

artículo científico publicado en 2006

Does prostate-specific antigen contribute to bone metastases?

artículo científico publicado en 2006

Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men.

artículo científico publicado en 2007

Dystrophic spinal deformities in a neurofibromatosis type 1 murine model

artículo científico publicado en 2015

Endothelins in bone cancer metastases

artículo científico publicado en 2004

Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis

artículo científico publicado en 2010

Erratum to: Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis

scholarly article published in Breast Cancer Research and Treatment

Estrogenic side effects of androgen deprivation therapy.

artículo científico publicado en 2007

Examining the Metastatic Niche: Targeting the Microenvironment ⬇️

artículo científico publicado el 1 de octubre de 2010

Excess TGF-β mediates muscle weakness associated with bone metastases in mice

artículo científico publicado en 2015

GLI2-mediated melanoma invasion and metastasis

artículo científico publicado en 2010

Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo

artículo científico publicado en 2002

Guide to bone health and disease in cystic fibrosis

artículo científico publicado en 2004

Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis

artículo científico publicado en 2017

Halofuginone inhibits the establishment and progression of melanoma bone metastases

artículo científico publicado en 2012

Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis

artículo científico publicado en 2012

Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.

artículo científico publicado en 2013

Hypercalcemia of Malignancy: A New Twist on an Old Problem

artículo científico publicado en 2016

Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment

artículo científico publicado en 2009

Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease

artículo científico publicado en 2020

Local effects of malignancy on bone

artículo científico publicado en 2007

Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice

artículo científico publicado en 2016

LyP-1-modified oncolytic adenoviruses targeting transforming growth factor β inhibit tumor growth and metastases and augment immune checkpoint inhibitor therapy in breast cancer mouse models

scientific article published on 12 May 2020

Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's disease

artículo científico publicado en 2016

Mechanisms and treatment for bone metastases.

artículo científico publicado en 2004

Mechanisms of Osteoblastic Metastases: Role of Endothelin-1 ⬇️

artículo científico publicado el 1 de octubre de 2003

Modulation of mammalian life span by the short isoform of p53.

artículo científico publicado en 2004

Molecular Mechanisms of Bone Metastasis and Therapeutic Implications ⬇️

artículo científico publicado el 1 de octubre de 2003

Molecular biology and therapeutics in musculoskeletal oncology

artículo científico publicado en 2009

Molecular biology of bone metastasis

artículo científico publicado en 2007

Molecular mechanisms and treatment of bone metastasis

artículo científico publicado en 2008

Molecular mechanisms of bone metastasis and associated muscle weakness

artículo científico publicado en 2014

Molecular mechanisms of breast cancer metastases to bone

artículo científico publicado en 2005

Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells

artículo científico publicado en 2017

New insights into the role of T cells in the vicious cycle of bone metastases

artículo científico publicado en 2006

Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis

artículo científico publicado en 2015

Optimizing and Profiling Prostaglandin E2 as a Medical Countermeasure for the Hematopoietic Acute Radiation Syndrome

scientific article published on 10 December 2020

Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

artículo científico publicado en 2008

Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model

artículo científico publicado en 2017

Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies

artículo científico publicado en 2004

Overexpression of parathyroid hormone-related protein causes hypercalcemia but not bone metastases in a murine model of mammary tumorigenesis

artículo científico publicado en 2002

Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin

artículo científico publicado en 2015

Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone

artículo científico publicado en 2008

Preserving Well-being in Patients With Advanced and Late Prostate Cancer

artículo científico publicado en 2020

Protein kinase Calpha regulates Ets1 transcriptional activity in invasive breast cancer cells.

artículo científico publicado en 2003

RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro

artículo científico publicado en 2013

Radium-223 mechanism of action: implications for use in treatment combinations

scientific article published on 11 November 2019

Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor ⬇️

artículo científico publicado el 1 de octubre de 2011

RhoGDI2 is an invasion and metastasis suppressor gene in human cancer

artículo científico publicado en 2005

Role of TGF-β in breast cancer bone metastases.

artículo científico publicado en 2013

Role of bisphosphonates in prostate cancer bone metastases ⬇️

artículo científico publicado el 1 de octubre de 2003

Role of endothelin-1 in osteoblastic bone metastases

artículo científico publicado en 2003

Single-Limb Irradiation Induces Local and Systemic Bone Loss in a Murine Model

artículo científico publicado en 2015

Skeletal metastases: decreasing tumor burden by targeting the bone microenvironment

artículo científico publicado en 2007

Skeletal muscle Ca(2+) mishandling: Another effect of bone-to-muscle signaling

artículo científico publicado en 2015

Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone Metastases

artículo científico publicado en 2015

Systemic delivery of an oncolytic adenovirus expressing soluble transforming growth factor-β receptor II-Fc fusion protein can inhibit breast cancer bone metastasis in a mouse model

artículo científico publicado en 2010

Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model

artículo científico publicado en 2012

TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone

artículo científico publicado en 2019

TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases

artículo científico publicado en 2010

TGF-β in cancer and bone: implications for treatment of bone metastases

artículo científico publicado en 2010

TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases ⬇️

artículo científico publicado el 12 de julio de 2011

TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis

artículo científico publicado en 2011

TGFβ-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis

artículo científico publicado en 2015

Tgf-Beta pathway as a therapeutic target in bone metastases.

artículo científico publicado en 2010

The Biology of Bone Metastasis

artículo científico publicado en 2018

The Role of TGFβ in Bone-Muscle Crosstalk

artículo científico publicado en 2017

The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone

artículo científico publicado en 2015

The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone

artículo científico publicado en 2003

The critical role of the bone microenvironment in cancer metastases

artículo científico publicado en 2009

The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1

artículo científico publicado en 2011

The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells

artículo científico publicado en 2006

The microenvironment matters: estrogen deficiency fuels cancer bone metastases

artículo científico publicado en 2014

The reaction of bone to tumor growth from human breast cancer cells in a rat spine single metastasis model

artículo científico publicado en 2011

The role of TGF-β in bone metastasis: novel therapeutic perspectives

artículo científico publicado en 2012

The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm

artículo científico publicado en 2017

Therapeutic Strategies to Target TGF-&#946; in the Treatment of Bone Metastases ⬇️

artículo científico publicado el 1 de diciembre de 2011

Transforming Growth Factor-Beta in Osteolytic Breast Cancer Bone Metastases ⬇️

artículo científico publicado el 1 de octubre de 2003

Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways

artículo científico publicado en 2002

Tumor-Bone Cell Interactions in Bone Metastases

Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway

artículo científico publicado en 2005

Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis

artículo científico publicado en 2014

Tumor–bone interactions: there is no place like bone

Understanding and Optimizing Bone Health in Breast Cancer ⬇️

artículo científico publicado el 5 de noviembre de 2010

c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions

artículo científico publicado en 2012

Lista de obras de Theresa A. Guise

A "Connexin" Responsible for the Fatal Attraction of Cancer to Bone

A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases

Actions of bisphosphonates in animal models of breast cancer

Ad5/48 hexon oncolytic virus expressing sTGFβRIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases

Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis

Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference

Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference

Agents targeting prostate cancer bone metastasis

Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker

Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation

Antitumor effects of bisphosphonates: promising preclinical evidence

Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo

Assessing new bone formation in neonatal calvarial organ cultures

BMP7: a new bone metastases prevention?

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer

Bone loss and fracture risk associated with cancer therapy

Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases

Breaking Down Barriers to Chemoresistance: Role of Chemotherapy-Induced Osteoblastic Jagged1.

Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases

Breaking new ground to build bone

Breast cancer bone metastases: it's all about the neighborhood

Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy

Cancer to bone: a fatal attraction ⬇️

Cancer treatment-related bone disease

Cancer-associated bone disease

Cancer-associated muscle weakness: What's bone got to do with it?

Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror

Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity

Corrigendum: Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin

Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis

Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad

Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy

Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation

Differential Bone Loss in Mouse Models of Colon Cancer Cachexia

Differential stem- and progenitor-cell trafficking by prostaglandin E2.

Do markers of bone turnover predict clinical outcome in patients with bone metastases?

Does prostate-specific antigen contribute to bone metastases?

Drug insight: the use of bisphosphonates for the prevention and treatment of osteoporosis in men.

Dystrophic spinal deformities in a neurofibromatosis type 1 murine model

Endothelins in bone cancer metastases

Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis

Erratum to: Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis

Estrogenic side effects of androgen deprivation therapy.

Examining the Metastatic Niche: Targeting the Microenvironment ⬇️

Excess TGF-β mediates muscle weakness associated with bone metastases in mice

GLI2-mediated melanoma invasion and metastasis

Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo

Guide to bone health and disease in cystic fibrosis

Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis

Halofuginone inhibits the establishment and progression of melanoma bone metastases

Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis

Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.

Hypercalcemia of Malignancy: A New Twist on an Old Problem

Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment

Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease

Local effects of malignancy on bone

Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice

LyP-1-modified oncolytic adenoviruses targeting transforming growth factor β inhibit tumor growth and metastases and augment immune checkpoint inhibitor therapy in breast cancer mouse models

Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's disease

Mechanisms and treatment for bone metastases.

Mechanisms of Osteoblastic Metastases: Role of Endothelin-1 ⬇️

Modulation of mammalian life span by the short isoform of p53.

Molecular Mechanisms of Bone Metastasis and Therapeutic Implications ⬇️

Molecular biology and therapeutics in musculoskeletal oncology

Molecular biology of bone metastasis

Molecular mechanisms and treatment of bone metastasis

Molecular mechanisms of bone metastasis and associated muscle weakness

Molecular mechanisms of breast cancer metastases to bone

Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells

New insights into the role of T cells in the vicious cycle of bone metastases

Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis

Optimizing and Profiling Prostaglandin E2 as a Medical Countermeasure for the Hematopoietic Acute Radiation Syndrome

Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.

Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model

Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies

Overexpression of parathyroid hormone-related protein causes hypercalcemia but not bone metastases in a murine model of mammary tumorigenesis

Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin

Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases ⬇️